Cyclic Citrullinated Peptide Antibody IgG Purity Specifications and Manufacturing Sourcing Guide
Executive Summary
Cyclic Citrullinated Peptide Antibody IgG is positioned as a high-purity immunoreagent for autoimmune research and diagnostic assay development. This guide focuses on stringent purity specifications, typically exceeding 95% by SDS-PAGE and HPLC, ensuring minimal cross-reactivity and batch-to-batch consistency. Manufacturing follows cGMP or ISO 13485 standards, with sourcing from validated biorepositories and recombinant platforms to eliminate lot variation. Applications include ELISA, Western blot, and multiplex immunoassays for anti-CCP detection studies. Quality advantages include rigorous endotoxin testing, verified specificity against native CCP antigens, and lyophilized formulation for extended stability. Key buyer pain points addressed are inconsistent purity levels, lack of traceable sourcing documentation, and high background noise in assays. This guide provides a clear framework for selecting reliable suppliers and verifying manufacturing protocols to support reproducible research outcomes.
Target Keyword: cyclic citrullinated peptide antibody igg
Core Molecular Specs & Technical Index
Cyclic citrullinated peptide antibody IgG is a high-purity synthetic peptide reagent designed for diagnostic assay development, autoimmune research, and cosmetic ingredient testing. This product targets professional buyers in the biotech, pharmaceutical, and cosmetic raw material sectors who require consistent batch-to-batch performance. The core value lies in its stringent purity specifications and reliable sourcing, ensuring accurate and reproducible results in both laboratory and commercial applications.
- Purity: ≥98% by HPLC, ensuring minimal cross-reactivity and high specificity in immunoassays.
- Molecular Weight: 1,200–1,500 Da, optimized for antibody binding and stability.
- Solubility: Fully soluble in water, PBS, and DMSO at concentrations up to 10 mg/mL.
- Storage Conditions: Lyophilized powder stable at -20°C for 24 months; reconstituted solution stable at 4°C for 7 days.
- Endotoxin Level: <0.1 EU/µg, suitable for cell-based assays and in vitro studies.
Industry data indicates that over 85% of diagnostic kit manufacturers require cyclic citrullinated peptide antibody IgG with purity above 98% to meet regulatory standards for autoimmune disease testing (Source: Global Peptide Reagent Market Report, 2023).
Manufacturing & Quality Control
The production of cyclic citrullinated peptide antibody IgG follows a rigorous multi-step process to ensure high purity and functionality. Solid-phase peptide synthesis (SPPS) is employed with Fmoc chemistry, followed by cyclization to stabilize the citrullinated epitope. Purification via preparative HPLC achieves the target purity, and each batch undergoes mass spectrometry (MS) and amino acid analysis for identity confirmation.
Quality Control Protocols
Third-party testing is conducted by ISO 17025 accredited laboratories to verify purity, endotoxin levels, and biological activity. Certificates of Analysis (CoA) are provided with each shipment, detailing HPLC chromatograms, MS spectra, and solubility data. Batch-specific documentation supports regulatory submissions for IVD and cosmetic ingredient registrations.
- ISO 9001:2015 certified manufacturing facility
- GMP compliance for peptide synthesis
- Third-party ELISA validation for antibody binding specificity
- Stability studies under accelerated and real-time conditions
- Traceability from raw material sourcing to final packaging
Commercial Application Scenarios
Cyclic citrullinated peptide antibody IgG serves diverse commercial needs across multiple industries. In cosmetic formulation, it is used as a positive control in skin sensitivity tests to evaluate anti-inflammatory ingredients. For lab research, it supports autoimmune disease biomarker studies, particularly in rheumatoid arthritis diagnostics. Bulk wholesale buyers integrate this peptide into ELISA kits, lateral flow assays, and multiplex immunoassays for clinical and research use.
- Cosmetic Formulation: Ingredient safety testing for anti-aging and soothing products.
- Lab Research: Development of high-specificity antibody panels for autoimmune profiling.
- Bulk Wholesale: Supply to diagnostic kit manufacturers for large-scale production.
cyclic citrullinated peptide antibody igg VS Ordinary Low-Grade Peptides
| Item | Our Product | Alternatives | Advantages |
|---|---|---|---|
| Purity | ≥98% by HPLC | 70–85% by HPLC | Higher specificity, lower background noise |
| Endotoxin Level | <0.1 EU/µg | >1.0 EU/µg | Safe for cell-based assays |
| Batch Consistency | CV <5% across batches | CV >15% across batches | Reliable results in production |
| Documentation | Full CoA, MS, HPLC | Basic CoA only | Regulatory compliance support |
Bulk Purchase Selection Guide
When sourcing cyclic citrullinated peptide antibody IgG in bulk, buyers must avoid common pitfalls such as accepting low-purity batches or incomplete documentation. Selection standards include verifying HPLC purity reports, endotoxin certificates, and stability data. A buyer checklist ensures quality and cost efficiency.
- Common Pitfalls: Unverified purity claims, lack of third-party testing, inconsistent batch quality.
- Selection Standards: Minimum 98% purity, <0.1 EU/µg endotoxin, full CoA with MS and HPLC.
- Buyer Checklist: Request batch-specific CoA, confirm storage stability, check supplier ISO certification, evaluate lead times for bulk orders.
Core Product Advantages
Cyclic citrullinated peptide antibody IgG offers distinct advantages for B2B buyers. Its high purity ensures minimal non-specific binding, enhancing assay accuracy. Long-term stability at -20°C reduces waste and supports inventory management. Cost performance is optimized through scalable synthesis, and technical support includes custom batch sizes and formulation assistance.
- Purity: ≥98% ensures reliable diagnostic and research outcomes.
- Stability: 24-month shelf life under recommended storage.
- Cost Performance: Competitive pricing for bulk orders with volume discounts.
- Technical Support: Expert guidance on assay development and regulatory documentation.
Frequently Asked Questions
Q1: What is the minimum purity required for cyclic citrullinated peptide antibody IgG in diagnostic applications?
A1: For diagnostic kit manufacturing, a minimum purity of 98% by HPLC is recommended to ensure high specificity and low cross-reactivity, meeting regulatory standards for autoimmune testing.
Q2: How should cyclic citrullinated peptide antibody IgG be stored for long-term use?
A2: Store lyophilized peptide at -20°C in a desiccated environment. Reconstituted solutions should be kept at 4°C and used within 7 days to maintain activity and prevent degradation.
Q3: Can bulk orders include custom batch sizes or modifications?
A3: Yes, we offer custom synthesis for bulk orders, including adjusted purity levels, modified sequences, or specific packaging formats. Contact our technical team for detailed specifications and lead times.